



At a new step in evolution of 
medical science and modern im-
proving technologies, to perform 
interest is again increasing to 
the diseases of the thymus gland 
(TG). This is due to the fact that 
the TG is the beneficial organ 
of the immune system of the 
body, as well as the internal gland 
of secretion. A great number of 
pathological processes which oc-
curs in our body deal with that 
dysfunction. Thymus cells are a 
significant part of the immune 
system and it can become the 
ground for the progress oncolog-
ical process [1, 2]. High organiza-
tion thymus tumors are a series 
of histological structure tumors 
that demonstrate options at the 
molecular rage of thymomas are 
the most common feature of neo-
plasms of the high vein, which 
occurs in 87.5 %. To designate 
them in 1900 H. Grandhomme 
and R. Scminke proposed the 
defenition “thymoma” [3].
Mediastinal neoplasms are 
difficult to identify and treat, 
because it often has a long as-
ymptomatic evolution period 
and clinical manifestations in 
the form of compression of the 
mediastinal organs. It should be 
noted, that thymoma is the one 
of the general primary neoplasm 
of the front mediastinum but 
case for malignancies less than 
2 % of all adult patients. More-
over, the histogenesis of tumors, more than a hundred of their 
morphological variants can arise [4, 5]. Currently, tumors are 
referred to as thymomas, developing from cells whose histogen-
esis is associated with the epithelium of the thymic parenchyma. 
However, thymic tumors are one of the most common forma-
tions of the anterior mediastinum and are detected in 10–40 % 
of patients whereas among all oncological diseases, thymomas 
are quite rarely (0.2–1.5 %). In men and women, this disease 
is noted in almost the same ratio, with frequency of 0.15 cases 
per 100,000 population. Thymomas are detected in patients of 
completely different ages. Cases of findings of a tumor of the 
thymus are described in an 8 month old child and a 90 year old 
patient [6]. Most thymomas are usually located in the mediasti-
num in front of it, in a typical place of localization of the TG, 
but probability of detecting a tumor is not limited the anatom-
ical location of this gland. In 1.1–2.2 % of cases, multicentric 
thymomas may occur, which is characterized by the presence 
in different parts of one gland of 2 neoplasms [7, 8]. Thymoma 
is an indication for elective surgery, and the most radical the 
method of treatment is thymomymectomy, which consists of the 
complete removal of the thymoma with veins, surrounding fat 
tissue and lymph nodes of the anterior mediastinum. For many 
years, full, and then a partial median sternotomy or thoracot-
omy. The evolution of video endoscopic systems, the advent 
of fiber-optic light guides and 
investigation have changed the 
methodological approaches to 
the surgical treatment of patients 
with thymomas. Have appeared 
scientific research publications 
on the removal of thymic tumors 
using mini-invasive technolo-
gies, such as videothoracoscopic 
operations [9, 10]. The using of 
videothoracoscopic technologies 
compared with open access, un-
doubtedly reduces surgical trau-
mas, risks of bleeding, the risk 
of respiratory and cardiovascu-
lar complications after surgical 
interventions due to less trau-
matic approach. Positive factors 
also include acceleration of re-
habilitation and reduction of the 
length of stay of patients in the 
surgical department [11].
The aim of the study: to 
learn retrospective analysis re-
sults of the surgical treatment of 
thymus tumours. 
2. Materials and research 
methods
The research is a retrospec-
tive analysis of observation data 
involving 36 patients with thy-
momas who were treated at the 
Department of Thoraco-abdom-
inal Surgery of the State Insti-
tution “Zaycev V. T. Institute of 
General and Urgent Surgery of 
the National Academy of Med-
ical Sciences of Ukraine” from 
September 2019 to May 2021. The 
control group included 20 patients with SVCS treated with con-
ventional techniques, while the experimental group included 16 
patients who underwent a novel bypass surgery developed by us.
The authors declare that all procedures and experiments 
of this study respect the ethical standards in the Helsinki Dec-
laration of 1975, as revised in 2008 (5), as well as the national 
law. Informed consent to participate in the study was discussed 
and signed by all study participants. Meeting of the Bioethics 
Commission (protocol No. 4 11.10.2021) of the State Institution 
“Zaycev V. T. Institute of General and Urgent Surgery of the 
National Academy of Medical Sciences of Ukraine”.
At the preoperative stage, all patients underwent standard 
diagnostic tests to assess the advancement of the tumour pro-
cess in the mediastinum and functional reserves: multislice 
computed tomography (MSCT) of thoracic and abdominal organs, 
comprehensive ultrasound test (including mediastinum ultra-
sound), electrocardiography, echocardiography, spirometry. Fi-
ber-optic bronchoscopy was performed in case of lung lesion. 
The most reliable method of diagnosing SVC invasion at the pre-
operative stage and assessing tumour advancement is considered 
to be MSCT with intravenous contrast enhancement with iso-os-
molar contrast, which does not cause a sharp blood pressure drop 
that is likely to cause a vascular collapse at the backdrop of reduced 
heart flow. SVC invasion is most precisely visualized in the early 
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twice as high in the control group as in the experimental 
group (standard error of relative risk equals 0.64).
Conclusion. The first mandatory step of the radical surgery 
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venous phase. Echocardiography is required to identify a tumour 
thrombus in the mediastinum. Besides, patients obligatorily un-
derwent doppler ultrasound test of upper limb and neck vessels. 
There was not found a significant difference in the number 
of patients, average age, gender composition, or body mass index 
(BMI) found between ОА groups (p>0.05).
The distribution of patients according to the TNM classi-
fication proposed by the World Health Organization in 2017 is 
shown in (Tables 1, 2). 
Table 1
Grouping stages by TNM
Stage I Stage II Stage IIIa
Stage 
IIIb Stage IVa Stage IVb
T1N0M0 T2N0M0 T3N0M0 T4N0M0
T(any)
N1M0; 
T (any) N 
(0.1), M1a
T (any) N2M 
(0.1a); 














The differences between the main and control groups are 
statistically significant (p<0.05) in Table 1.
Table 2
Grouping patients depend on stages by TNM:





T1N0M0 T2N0M0 T3N0M0 T4N0M0 T (any) N1M0
T (any) N2M 














Depending on from the predominance of a clinical symptom, 
we single out the following options for compression syndrome 
(classification by V. V. Boyko et al., 2009), I stage – syndrome of 
the superior vena cava, II stage – syndrome of compression of 
the trachea and bronchi, III stage – syndrome of compression of 
the pulmonary veins, IV stage – compression syndrome of the 
aortic arch and its branches, V stage – syndrome of the inferior 
vena cava, VI stage – syndrome of compression of the heart, 
VII stage – syndrome of nerve plexus compression, VIII stage – 
combined compression syndrome rum of the mediastinum 
(damage to 2 anatomical zones and more).
Ethics review. All patients signed a voluntary informed con-
sent for the examination and treatment, as well as publication of 
anonymized personal medical information for academic purposes.
Statistical analysis. Findings concerning the effectiveness of 
different surgical interventions were analysed using non-para-
metric statistical techniques (analysis of two-dimensional fre-
quency distributions based on the chi-squared criterion and 
relative risk). The differences between the main and control 
groups are statistically significant (p<0.05).
3. Results
Traditional infusion in the SVC system veins significantly 
increases venous hypertension and oedema of the upper half 
of the body. To avoid this, femoral veins were catheterized and 
the medicines were administered intra-arterially (mostly in the 
radial artery). In patients from the experimental group, where 
the tumour could not be resected for technical reasons, venous 
bypass was performed to correct SVCS. 
In 5 (19.2 %) cases, the auriculo-jugular bypass was used as 
an auxiliary stage in radical resection of thymoma tumours. In 
our opinion, resecting a tumour with SVC invasion without a 
prior bypass is a mistake that may cause a lethal outcome. SVC 
transection or its acute thrombosis during the tumour resection 
causes a rapid increase in the central venous pressure with all 
the ensuing consequences. In certain cases, the near-tumoral 
thrombus or tumoral tissue may get detached and migrate to 
the right heart compartments, leading to the development of the 
pulmonary embolism. 
Complications in the post-operative period were reported 
in 3 (11.5 %) patients from the experimental group and included 
auriculo-subclavian bypass thrombosis in 1 (3.8 %) case, pneu-
monia in 1 (3.8 %) case. Post-operative lethality in the study 
groups was reported for 4 (13.3 %) patients in the control group 
and 1 (3.8 %) patient in the experimental group. Total lethality 
rate was 8.9 % (5 patients). 
The relative risk of complications and lethal outcome was cal-
culated for patients from both groups. It was found that the risk 
of complications was twice as high in the control group as in the 
experimental group (standard error of relative risk equals 0.64), 
whereas the risk of lethal outcome increased by a factor of 3.5 
in the control group (standard error of relative risk equals 1.09).
There was not found a significant difference in the number 
of patients, average age, gender composition, or body mass index 
(BMI) found between ОА groups (p>0.05).
4. Discussion
In our research, which is a retrospective analysis of obser-
vation of the results of surgical treatment for 56 patients with 
locally advanced thymomas complicated by SVCS. The control 
group included 30 patients with SVCS treated with conventional 
techniques, while the experimental group included 26 patients 
who underwent a new bypass surgery developed by us [6, 11].
In patients with locally advanced thymomas, constantly 
increased pressure in the SVC system for several months leads 
to progressive dilatation and development of a network of col-
lateral venous blood flow. Owing to this mechanism, the SVCS 
remains at the compensation or sub-compensation stage for a 
rather long time [5, 7].
It should be noted that in the structure of complications 
in the post-operative period in our study, the leading place is 
occupied by auriculo-subclavian bypass thrombosis in 3.8 % 
of patients [6, 11]. So, in our study, pneumonia was in 3.8 % of 
patients. Thromboembolism of small pulmonary arteries in 
3.8 % of patients whereas in 23.4 % of patients’ post-operative 
complications were reported in the control group including 
haemorrhage from the sternotomy wound in 3.3 % of patients. 
Also, superior vena cava thrombosis in 6.6 % of patients while 
pneumonia in 6.6 % of patients. However, thromboembolism of 
small pulmonary arteries in 6.6 % of patients [3, 11]. 
Study limitations. This study combines the results of a 
retrospective analysis of observation of the results of surgical 
treatment patients with thymomas complicated by SVCS. Since 
the use of the venous bypass to improve results in the postoper-
ative period and realize the full effect of treatment in patients. 
Prospects for the future research. Since the usage of by-
pass methods of surgical treatment and conservative treatment 
patients with thymomas complicated by SVCS can notice to im-
proving of surgical results, we plan to develop an algorithm that 




The superior vena cava syndrome in 56 patients (26 (46 %) in 
the experimental group and 30 (54 %) in the control group) with 
locally advanced thymoma is an emergency condition whose sur-
gical correction must be personalised depending on the anatomic 
and topographic classification of SVC lesion types. An obligatory 
pre-condition of the perioperative period in this category of patients 
is an adequate vascular approach to the superior vena cava system.
The first mandatory step of the radical surgery in patients 
with locally advanced thymomas with SVC invasion should be 
the auriculo-jugular ASA II 37 (66.1 %), (p<0.05). 
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